Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases.
Publication
, Journal Article
Wegermann, K; Diehl, AM
Published in: Hepatology
July 1, 2023
Duke Scholars
Published In
Hepatology
DOI
EISSN
1527-3350
Publication Date
July 1, 2023
Volume
78
Issue
1
Start / End Page
8 / 9
Location
United States
Related Subject Headings
- Proteomics
- Metabolic Diseases
- Liver Diseases
- Humans
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Wegermann, K., & Diehl, A. M. (2023). Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases. Hepatology, 78(1), 8–9. https://doi.org/10.1097/HEP.0000000000000385
Wegermann, Kara, and Anna Mae Diehl. “Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases.” Hepatology 78, no. 1 (July 1, 2023): 8–9. https://doi.org/10.1097/HEP.0000000000000385.
Wegermann K, Diehl AM. Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases. Hepatology. 2023 Jul 1;78(1):8–9.
Wegermann, Kara, and Anna Mae Diehl. “Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases.” Hepatology, vol. 78, no. 1, July 2023, pp. 8–9. Pubmed, doi:10.1097/HEP.0000000000000385.
Wegermann K, Diehl AM. Population-based proteomics: Platforms to advance diagnosis and treatment of metabolic liver diseases. Hepatology. 2023 Jul 1;78(1):8–9.
Published In
Hepatology
DOI
EISSN
1527-3350
Publication Date
July 1, 2023
Volume
78
Issue
1
Start / End Page
8 / 9
Location
United States
Related Subject Headings
- Proteomics
- Metabolic Diseases
- Liver Diseases
- Humans
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics